Cancer‐associated fibroblasts can activate epithelial to mesenchymal transition (EMT) in pancreatic cancer,73 and the fibroblast GO biological pathway was also characterised by SPARC expression, which promotes tumour cell invasiveness in triple negative breast cancer when released by fibroblasts.74 The gene discussed is SPARC; the disease is triple-negative breast carcinoma.